Proactive Infliximab Is Superior to Either Conventional Infliximab and Vedolizumab in Inflammatory Bowel Disease
AuthID
P-00W-HHY
P-00W-HHY
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service